Form D/A
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
BIOTECHNOLOGY VALUE FUND L P
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago
Entity Type
LIMITED PARTNERSHIP
Item 2 Issuer Principal Place of Business and Contact Information
900 N. MICHIGAN AVENUE, SUITE 1100
CHICAGO, IL 60611
Phone Number:
subscription required
Item 3. Related Persons
Name
N/A BVF PARTNERS, L.P.
Address
subscription required
Relationship(s)
Clarification of Response
GENERAL PARTNER
Item 3. Related Persons
Name
N/A BVF INC.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MARK N LAMPERT
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MATTHEW D PERRY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
OLEG NODELMAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
POOLED INVESTMENT FUND
- HEDGE FUND
Item 5. Issuer Size
Aggregate Net Asset Value Range (for issuer specifying "hedge" or "other investment" fund in item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
Amendment
Date of First Sale in this Offering:
09/01/2008
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
Yes
Item 9. Type(s) of Securities Offered
- Pooled Investment Fund Interests
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
INDEFINITE
Total Amount Sold
29155500
Total Remaining to be Sold
INDEFINITE
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
12
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
BIOTECHNOLOGY VALUE FUND L P
Issuer Signature
MARK N. LAMPERT
Signer Name
MARK N. LAMPERT
Signer Title
DIRECTOR OF THE GENERAL PARTNER OF THE GENERAL PARTNER
Signature Date
10/15/2009